Xencor (XNCR) News Today $7.52 -0.62 (-7.62%) Closing price 04:00 PM EasternExtended Trading$7.76 +0.24 (+3.20%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XNCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Xencor (NASDAQ:XNCR) vs. Dermata Therapeutics (NASDAQ:DRMA) Financial ComparisonMay 19 at 1:15 AM | americanbankingnews.comXencor, Inc. (NASDAQ:XNCR) Shares Acquired by RTW Investments LPRTW Investments LP lifted its holdings in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 317.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,402,883 shares of the biopharmaceutical company's stock after buying an additional 1,827,883 sharesMay 18 at 6:54 AM | marketbeat.comPoint72 Asset Management L.P. Sells 943,148 Shares of Xencor, Inc. (NASDAQ:XNCR)Point72 Asset Management L.P. lowered its stake in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 30.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,177,081 shares of the biopharmaceutical company's stock after selling 943,148 shares during the quarter. PoMay 18 at 6:15 AM | marketbeat.comNorthern Trust Corp Increases Holdings in Xencor, Inc. (NASDAQ:XNCR)Northern Trust Corp boosted its holdings in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 19.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 747,152 shares of the biopharmaceutical company's sMay 17, 2025 | marketbeat.comBrokerages Set Xencor, Inc. (NASDAQ:XNCR) Price Target at $29.50May 17, 2025 | americanbankingnews.comXencor, Inc. (NASDAQ:XNCR) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Xencor, Inc. (NASDAQ:XNCR - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven haveMay 16, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Raises Stock Position in Xencor, Inc. (NASDAQ:XNCR)Jacobs Levy Equity Management Inc. lifted its holdings in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 150.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 519,976 shares of the biopharmaceutical companMay 15, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV), Xencor (XNCR) and Intellia Therapeutics (NTLA)May 13, 2025 | theglobeandmail.comLeerink Partnrs Has Bearish Forecast for Xencor Q2 EarningsXencor, Inc. (NASDAQ:XNCR - Free Report) - Investment analysts at Leerink Partnrs lowered their Q2 2025 earnings estimates for Xencor in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst J. Chang now anticipates that the biopharmaceutical company will post earnings per share oMay 13, 2025 | marketbeat.comWedbush Comments on Xencor's Q2 Earnings (NASDAQ:XNCR)Xencor, Inc. (NASDAQ:XNCR - Free Report) - Equities researchers at Wedbush cut their Q2 2025 earnings per share (EPS) estimates for Xencor in a report issued on Wednesday, May 7th. Wedbush analyst D. Nierengarten now forecasts that the biopharmaceutical company will post earnings per share of ($0May 13, 2025 | marketbeat.comResearch Analysts Set Expectations for Xencor Q2 EarningsXencor, Inc. (NASDAQ:XNCR - Free Report) - Investment analysts at William Blair dropped their Q2 2025 earnings per share estimates for Xencor in a research report issued to clients and investors on Wednesday, May 7th. William Blair analyst M. Phipps now forecasts that the biopharmaceutical companMay 13, 2025 | marketbeat.comLeerink Partnrs Estimates Xencor's Q2 Earnings (NASDAQ:XNCR)May 13, 2025 | americanbankingnews.comWedbush Weighs in on Xencor's Q2 Earnings (NASDAQ:XNCR)May 13, 2025 | americanbankingnews.comEquities Analysts Offer Predictions for Xencor Q2 EarningsMay 13, 2025 | americanbankingnews.comWhat is William Blair's Forecast for Xencor Q4 Earnings?May 11, 2025 | americanbankingnews.comDeep Track Capital LP Has $11.49 Million Stake in Xencor, Inc. (NASDAQ:XNCR)Deep Track Capital LP reduced its holdings in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 37.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 500,000 shares of the biopharmaceutical company's stock afMay 9, 2025 | marketbeat.comBraidwell LP Buys 149,083 Shares of Xencor, Inc. (NASDAQ:XNCR)Braidwell LP raised its position in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 32.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 615,531 shares of the biopharmaceutical company's stock after purchasing an additional 149,083 shares during the quMay 8, 2025 | marketbeat.comXencor Reports First Quarter 2025 Financial ResultsMay 7, 2025 | uk.finance.yahoo.comXencor (NASDAQ:XNCR) Trading Down 6.1% - Should You Sell?Xencor (NASDAQ:XNCR) Trading Down 6.1% - Here's What HappenedMay 7, 2025 | marketbeat.comXencor, Inc. (NASDAQ:XNCR) EVP Nancy Valente Sells 4,616 SharesMay 7, 2025 | insidertrades.comDimensional Fund Advisors LP Grows Position in Xencor, Inc. (NASDAQ:XNCR)Dimensional Fund Advisors LP grew its position in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 7.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,501,532 shares of the biopharmaceutical company's stoMay 7, 2025 | marketbeat.comBVF Inc. IL Acquires 1,438,760 Shares of Xencor, Inc. (NASDAQ:XNCR)BVF Inc. IL grew its holdings in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 169.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,288,760 shares of the biopharmaceutical company's stock after acquiring an additional 1,438,760 shares during theMay 6, 2025 | marketbeat.comXencor (XNCR) Expected to Announce Earnings on ThursdayXencor (NASDAQ:XNCR) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-xencor-inc-stock/)May 3, 2025 | marketbeat.comRaymond James Financial Inc. Invests $2.33 Million in Xencor, Inc. (NASDAQ:XNCR)Raymond James Financial Inc. bought a new position in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 101,346 shares of the biopharmaceutical compMay 2, 2025 | marketbeat.comTCG Crossover Management LLC Acquires 25,000 Shares of Xencor, Inc. (NASDAQ:XNCR)TCG Crossover Management LLC boosted its stake in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,452,138 shares of the biopharmaceutical company's stock after purchaMay 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Purchases 107,350 Shares of Xencor, Inc. (NASDAQ:XNCR)Price T Rowe Associates Inc. MD grew its position in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 2.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,036,412 shares of the biopharmaceutical comApril 30, 2025 | marketbeat.comBarclays PLC Boosts Stock Position in Xencor, Inc. (NASDAQ:XNCR)Barclays PLC increased its position in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 112.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 330,745 shares of the biopharmaceutical company's stock after buying an additionApril 26, 2025 | marketbeat.comWilliam Blair Predicts Xencor's Q1 Earnings (NASDAQ:XNCR)Xencor, Inc. (NASDAQ:XNCR - Free Report) - Analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of Xencor in a research note issued to investors on Monday, April 21st. William Blair analyst M. Phipps anticipates that the biopharmaceutical company will earn ($0.84April 25, 2025 | marketbeat.comInvesco Ltd. Sells 156,130 Shares of Xencor, Inc. (NASDAQ:XNCR)Invesco Ltd. reduced its stake in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 25.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 454,745 shares of the biopharmaceutical company's stock after selling 156,130 shares during the peApril 25, 2025 | marketbeat.comXencor (NASDAQ:XNCR) Shares Down 2.7% - Here's WhyXencor (NASDAQ:XNCR) Stock Price Down 2.7% - Time to Sell?April 24, 2025 | marketbeat.comXencor (NASDAQ:XNCR) Stock Price Up 9.3% - Here's What HappenedXencor (NASDAQ:XNCR) Shares Up 9.3% - Time to Buy?April 23, 2025 | marketbeat.comXencor (NASDAQ:XNCR) Now Covered by William BlairWilliam Blair initiated coverage on Xencor in a research note on Monday. They issued an "outperform" rating on the stock.April 23, 2025 | marketbeat.comWilliam Blair starts Xencor stock with Outperform ratingApril 23, 2025 | uk.investing.comWilliam Blair Initiates Coverage of Xencor (XNCR) with Outperform RecommendationApril 22, 2025 | msn.comXencor initiated with an Outperform at William BlairApril 21, 2025 | markets.businessinsider.comXencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of "Buy" by AnalystsXencor, Inc. (NASDAQ:XNCR - Get Free Report) has been given a consensus rating of "Buy" by the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the companApril 20, 2025 | marketbeat.comXencor participates in a conference call with JPMorganApril 19, 2025 | markets.businessinsider.comXencor (NASDAQ:XNCR) Stock Price Up 4.9% - What's Next?Xencor (NASDAQ:XNCR) Trading Up 4.9% - Here's What HappenedApril 17, 2025 | marketbeat.comGeode Capital Management LLC Acquires 179,526 Shares of Xencor, Inc. (NASDAQ:XNCR)Geode Capital Management LLC increased its stake in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 12.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,634,876 shares of the biopharmaceutical company's stocApril 17, 2025 | marketbeat.comNorges Bank Buys New Position in Xencor, Inc. (NASDAQ:XNCR)Norges Bank purchased a new position in Xencor, Inc. (NASDAQ:XNCR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 147,823 shares of the biopharmaceutical company's stock, valued at approximately $3,397,April 13, 2025 | marketbeat.comXencor, Inc.: No Major Near Term CatalystsApril 11, 2025 | seekingalpha.comXencor, Inc. (NASDAQ:XNCR) Shares Sold by Trexquant Investment LPTrexquant Investment LP cut its holdings in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 59.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 83,241 shares of the biopharmaceutical company's stock afApril 11, 2025 | marketbeat.comXencor (NASDAQ:XNCR) Shares Down 5.4% - What's Next?Xencor (NASDAQ:XNCR) Stock Price Down 5.4% - What's Next?April 10, 2025 | marketbeat.comXencor’s SWOT analysis: biotech stock faces pivotal year aheadApril 10, 2025 | uk.investing.comXencor (NASDAQ:XNCR) Reaches New 52-Week Low - What's Next?Xencor (NASDAQ:XNCR) Sets New 52-Week Low - Should You Sell?April 9, 2025 | marketbeat.comADAR1 Capital Management LLC Sells 107,655 Shares of Xencor, Inc. (NASDAQ:XNCR)ADAR1 Capital Management LLC decreased its stake in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 31.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 234,607 shares of the biopharmaceuticaApril 9, 2025 | marketbeat.comFinepoint Capital LP Purchases Shares of 660,000 Xencor, Inc. (NASDAQ:XNCR)Finepoint Capital LP acquired a new position in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 660,000 shares of the biopharmaceutical company's stock, valued at approximatelApril 8, 2025 | marketbeat.comXencor, Inc. (NASDAQ:XNCR) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. lifted its stake in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,017,366 shares of the biopharmaceutical company's sApril 8, 2025 | marketbeat.comBarclays Keeps Their Sell Rating on Xencor (XNCR)April 3, 2025 | markets.businessinsider.comXencor (NASDAQ:XNCR) Trading Down 7.4% - Here's What HappenedXencor (NASDAQ:XNCR) Trading Down 7.4% - Should You Sell?April 3, 2025 | marketbeat.com Get Xencor News Delivered to You Automatically Sign up to receive the latest news and ratings for XNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address XNCR Media Mentions By Week XNCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XNCR News Sentiment▼0.520.65▲Average Medical News Sentiment XNCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XNCR Articles This Week▼74▲XNCR Articles Average Week Get Xencor News Delivered to You Automatically Sign up to receive the latest news and ratings for XNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mirum Pharmaceuticals News Apellis Pharmaceuticals News Arrowhead Pharmaceuticals News Vericel News NewAmsterdam Pharma News Ascentage Pharma Group International News Belite Bio News Harmony Biosciences News Denali Therapeutics News Kymera Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XNCR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xencor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xencor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
